FONAR Corporation (FONR)
USD 13.8
(1.92%)
USD 13.8
(1.92%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 | 16.53 Million USD | 11.81% |
| 2023 | 14.78 Million USD | -32.8% |
| 2022 | 22 Million USD | 28.71% |
| 2021 | 17.09 Million USD | 94.13% |
| 2020 | 8.8 Million USD | -60.21% |
| 2019 | 22.13 Million USD | 12.45% |
| 2018 | 19.68 Million USD | 3.08% |
| 2017 | 19.09 Million USD | 33.02% |
| 2016 | 14.35 Million USD | 11.28% |
| 2015 | 12.89 Million USD | 4.85% |
| 2014 | 12.3 Million USD | 63.26% |
| 2013 | 7.53 Million USD | 4.57% |
| 2012 | 7.2 Million USD | 90.07% |
| 2011 | 3.79 Million USD | 246.91% |
| 2010 | -2.58 Million USD | -266.61% |
| 2009 | -703.93 Thousand USD | 97.23% |
| 2008 | -25.45 Million USD | 0.0% |
| 2007 | -25.45 Million USD | 14.37% |
| 2006 | -29.72 Million USD | -1887.08% |
| 2005 | 1.66 Million USD | 119.64% |
| 2004 | -8.47 Million USD | 44.08% |
| 2003 | -15.14 Million USD | 23.2% |
| 2002 | -19.72 Million USD | -21.64% |
| 2001 | -16.21 Million USD | 1.29% |
| 2000 | -16.42 Million USD | -5.3% |
| 1999 | -15.6 Million USD | 11.36% |
| 1998 | -17.6 Million USD | 27.87% |
| 1997 | -24.4 Million USD | -171.11% |
| 1996 | -9 Million USD | -38.46% |
| 1995 | -6.5 Million USD | -160.0% |
| 1994 | -2.5 Million USD | -25.0% |
| 1993 | -2 Million USD | -433.33% |
| 1992 | 600 Thousand USD | -82.86% |
| 1991 | 3.5 Million USD | -37.5% |
| 1990 | 5.6 Million USD | 154.9% |
| 1989 | -10.2 Million USD | -400.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q3 | 3.74 Million USD | -23.32% |
| 2024 Q2 | 4.88 Million USD | -25.66% |
| 2024 Q1 | 6.57 Million USD | 164.93% |
| 2024 Q4 | 1.33 Million USD | -64.41% |
| 2023 Q4 | 2.48 Million USD | -40.48% |
| 2023 FY | 14.78 Million USD | -32.8% |
| 2023 Q1 | 3.91 Million USD | -5.63% |
| 2023 Q2 | 4.23 Million USD | 8.21% |
| 2023 Q3 | 4.16 Million USD | -1.54% |
| 2022 FY | 22 Million USD | 28.71% |
| 2022 Q1 | 5.74 Million USD | 49.36% |
| 2022 Q4 | 4.14 Million USD | -26.5% |
| 2022 Q3 | 5.63 Million USD | -13.03% |
| 2022 Q2 | 6.48 Million USD | 12.92% |
| 2021 Q3 | 4.12 Million USD | -17.26% |
| 2021 FY | 17.09 Million USD | 94.13% |
| 2021 Q1 | 4.15 Million USD | 684.62% |
| 2021 Q2 | 4.98 Million USD | 20.05% |
| 2021 Q4 | 3.84 Million USD | -6.75% |
| 2020 Q4 | 528.91 Thousand USD | -79.77% |
| 2020 FY | 8.8 Million USD | -60.21% |
| 2020 Q1 | 5.48 Million USD | 36.87% |
| 2020 Q2 | 5.02 Million USD | -8.48% |
| 2020 Q3 | 2.61 Million USD | -47.92% |
| 2019 FY | 22.13 Million USD | 12.45% |
| 2019 Q1 | 5.53 Million USD | 18.16% |
| 2019 Q3 | 6.6 Million USD | 10.5% |
| 2019 Q4 | 4 Million USD | -39.34% |
| 2019 Q2 | 5.98 Million USD | 8.0% |
| 2018 Q3 | 4.4 Million USD | -24.23% |
| 2018 Q2 | 5.81 Million USD | 21.42% |
| 2018 FY | 19.68 Million USD | 3.08% |
| 2018 Q4 | 4.68 Million USD | 6.46% |
| 2018 Q1 | 4.78 Million USD | 28.21% |
| 2017 Q4 | 3.73 Million USD | -37.82% |
| 2017 FY | 19.09 Million USD | 33.02% |
| 2017 Q1 | 4.75 Million USD | 96.52% |
| 2017 Q2 | 4.6 Million USD | -3.03% |
| 2017 Q3 | 6 Million USD | 30.22% |
| 2016 Q3 | 4.09 Million USD | -3.03% |
| 2016 Q4 | 2.41 Million USD | -40.97% |
| 2016 Q1 | 3.61 Million USD | 13.08% |
| 2016 Q2 | 4.22 Million USD | 16.87% |
| 2016 FY | 14.35 Million USD | 11.28% |
| 2015 Q3 | 2.66 Million USD | -25.9% |
| 2015 Q4 | 3.19 Million USD | 19.91% |
| 2015 FY | 12.89 Million USD | 4.85% |
| 2015 Q2 | 3.59 Million USD | 4.65% |
| 2015 Q1 | 3.43 Million USD | 30.49% |
| 2014 FY | 12.3 Million USD | 63.26% |
| 2014 Q1 | 4.05 Million USD | 75.63% |
| 2014 Q2 | 3.29 Million USD | -18.7% |
| 2014 Q3 | 2.31 Million USD | -29.62% |
| 2014 Q4 | 2.63 Million USD | 13.61% |
| 2013 Q1 | 1.87 Million USD | -3.67% |
| 2013 Q4 | 2.3 Million USD | 41.58% |
| 2013 Q3 | 1.63 Million USD | -5.34% |
| 2013 Q2 | 1.72 Million USD | -8.21% |
| 2013 FY | 7.53 Million USD | 4.57% |
| 2012 Q3 | 1.6 Million USD | -15.36% |
| 2012 Q2 | 1.89 Million USD | 7.55% |
| 2012 Q1 | 1.76 Million USD | 228.87% |
| 2012 FY | 7.2 Million USD | 90.07% |
| 2012 Q4 | 1.94 Million USD | 21.49% |
| 2011 Q3 | 1.37 Million USD | -4.5% |
| 2011 Q4 | 535.46 Thousand USD | -61.14% |
| 2011 Q2 | 1.44 Million USD | 231.72% |
| 2011 FY | 3.79 Million USD | 246.91% |
| 2011 Q1 | 435 Thousand USD | 422.4% |
| 2010 Q2 | -1.26 Million USD | 10.9% |
| 2010 Q1 | -1.42 Million USD | -347.26% |
| 2010 FY | -2.58 Million USD | -266.61% |
| 2010 Q4 | 83.27 Thousand USD | 233.08% |
| 2010 Q3 | 25 Thousand USD | 101.97% |
| 2009 Q4 | -317.93 Thousand USD | -141.72% |
| 2009 Q2 | 701 Thousand USD | 137.93% |
| 2009 Q3 | 762 Thousand USD | 8.7% |
| 2009 Q1 | -1.84 Million USD | 87.47% |
| 2009 FY | -703.93 Thousand USD | 97.23% |
| 2008 Q4 | -14.74 Million USD | -442.06% |
| 2008 FY | -25.45 Million USD | 0.0% |
| 2008 Q2 | -3.87 Million USD | 5.6% |
| 2008 Q1 | -4.1 Million USD | 52.52% |
| 2008 Q3 | -2.72 Million USD | 29.8% |
| 2007 FY | -25.45 Million USD | 14.37% |
| 2007 Q4 | -8.64 Million USD | -62.7% |
| 2007 Q3 | -5.31 Million USD | 1.56% |
| 2007 Q2 | -5.39 Million USD | 11.36% |
| 2007 Q1 | -6.09 Million USD | 30.69% |
| 2006 FY | -29.72 Million USD | -1887.08% |
| 2006 Q4 | -8.78 Million USD | -19.44% |
| 2006 Q3 | -7.35 Million USD | -32.72% |
| 2006 Q2 | -5.54 Million USD | 31.0% |
| 2006 Q1 | -8.03 Million USD | -1715.01% |
| 2005 Q2 | 1.22 Million USD | 34.84% |
| 2005 FY | 1.66 Million USD | 119.64% |
| 2005 Q4 | -442.69 Thousand USD | -1670.79% |
| 2005 Q1 | 907 Thousand USD | 205.18% |
| 2005 Q3 | -25 Thousand USD | -102.04% |
| 2004 Q4 | -862.29 Thousand USD | 38.67% |
| 2004 Q1 | -3.73 Million USD | 7.66% |
| 2004 Q2 | -2.46 Million USD | 34.13% |
| 2004 Q3 | -1.4 Million USD | 42.92% |
| 2004 FY | -8.47 Million USD | 44.08% |
| 2003 Q4 | -4.04 Million USD | 31.24% |
| 2003 FY | -15.14 Million USD | 23.2% |
| 2003 Q2 | -2.86 Million USD | -11.98% |
| 2003 Q3 | -5.88 Million USD | -105.26% |
| 2003 Q1 | -2.56 Million USD | 69.72% |
| 2002 Q2 | -4.03 Million USD | -19.19% |
| 2002 FY | -19.72 Million USD | -21.64% |
| 2002 Q4 | -8.46 Million USD | -119.74% |
| 2002 Q3 | -3.85 Million USD | 4.47% |
| 2002 Q1 | -3.38 Million USD | 37.72% |
| 2001 FY | -16.21 Million USD | 1.29% |
| 2001 Q1 | -3.99 Million USD | 15.2% |
| 2001 Q4 | -5.43 Million USD | -92.17% |
| 2001 Q3 | -2.82 Million USD | 28.6% |
| 2001 Q2 | -3.95 Million USD | 1.03% |
| 2000 Q3 | -3.93 Million USD | 10.48% |
| 2000 Q4 | -4.71 Million USD | -19.71% |
| 2000 FY | -16.42 Million USD | -5.3% |
| 2000 Q1 | -3.5 Million USD | 22.22% |
| 2000 Q2 | -4.4 Million USD | -25.71% |
| 1999 Q2 | -3.8 Million USD | -15.15% |
| 1999 Q3 | -4.1 Million USD | -7.89% |
| 1999 Q4 | -4.5 Million USD | -9.76% |
| 1999 Q1 | -3.3 Million USD | 50.0% |
| 1999 FY | -15.6 Million USD | 11.36% |
| 1998 FY | -17.6 Million USD | 27.87% |
| 1998 Q4 | -6.6 Million USD | -53.49% |
| 1998 Q2 | -3.5 Million USD | -9.38% |
| 1998 Q3 | -4.3 Million USD | -22.86% |
| 1998 Q1 | -3.2 Million USD | 78.67% |
| 1997 Q3 | -4.1 Million USD | -36.67% |
| 1997 Q1 | -2.4 Million USD | 50.0% |
| 1997 FY | -24.4 Million USD | -171.11% |
| 1997 Q4 | -15 Million USD | -265.85% |
| 1997 Q2 | -3 Million USD | -25.0% |
| 1996 Q2 | -1.2 Million USD | -71.43% |
| 1996 Q4 | -4.8 Million USD | -92.0% |
| 1996 FY | -9 Million USD | -38.46% |
| 1996 Q1 | -700 Thousand USD | 85.71% |
| 1996 Q3 | -2.5 Million USD | -108.33% |
| 1995 Q2 | -300 Thousand USD | 0.0% |
| 1995 FY | -6.5 Million USD | -160.0% |
| 1995 Q1 | -300 Thousand USD | 66.67% |
| 1995 Q4 | -4.9 Million USD | -390.0% |
| 1995 Q3 | -1 Million USD | -233.33% |
| 1994 Q4 | -900 Thousand USD | -550.0% |
| 1994 FY | -2.5 Million USD | -25.0% |
| 1994 Q3 | 200 Thousand USD | 120.0% |
| 1994 Q2 | -1 Million USD | -25.0% |
| 1994 Q1 | -800 Thousand USD | 65.22% |
| 1993 FY | -2 Million USD | -433.33% |
| 1993 Q4 | -2.3 Million USD | -475.0% |
| 1993 Q2 | 300 Thousand USD | 50.0% |
| 1993 Q3 | -400 Thousand USD | -233.33% |
| 1993 Q1 | 200 Thousand USD | 125.0% |
| 1992 FY | 600 Thousand USD | -82.86% |
| 1992 Q1 | 800 Thousand USD | 106.84% |
| 1992 Q2 | 4.4 Million USD | 450.0% |
| 1992 Q3 | 400 Thousand USD | -90.91% |
| 1992 Q4 | -800 Thousand USD | -300.0% |
| 1991 Q2 | 5.4 Million USD | 5.88% |
| 1991 Q1 | 5.1 Million USD | 126.29% |
| 1991 Q4 | -11.7 Million USD | -348.94% |
| 1991 FY | 3.5 Million USD | -37.5% |
| 1991 Q3 | 4.7 Million USD | -12.96% |
| 1990 FY | 5.6 Million USD | 154.9% |
| 1990 Q1 | 8.3 Million USD | 118.61% |
| 1990 Q2 | 8.3 Million USD | 0.0% |
| 1990 Q3 | 8.3 Million USD | 0.0% |
| 1990 Q4 | -19.4 Million USD | -333.73% |
| 1989 Q2 | 11.5 Million USD | 0.0% |
| 1989 Q1 | 11.5 Million USD | 0.0% |
| 1989 FY | -10.2 Million USD | -400.0% |
| 1989 Q4 | -44.6 Million USD | -487.83% |
| 1989 Q3 | 11.5 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Acutus Medical, Inc. | -14.36 Million USD | 215.141% |
| Cerus Corporation | -30.05 Million USD | 155.021% |
| OrthoPediatrics Corp. | -25.76 Million USD | 164.175% |
| PetVivo Holdings, Inc. | -10.62 Million USD | 255.681% |
| Talis Biomedical Corporation | -66.81 Million USD | 124.748% |
| Vivos Therapeutics, Inc. | -17.29 Million USD | 195.602% |
| Inogen, Inc. | -109.38 Million USD | 115.117% |
| Spectral AI, Inc. | -12.98 Million USD | 227.352% |
| Nano-X Imaging Ltd. | -62.58 Million USD | 126.419% |
| CVRx, Inc. | -43.1 Million USD | 138.362% |
| DIH Holding US, Inc. Warrants | -3.52 Million USD | 568.689% |
| Helius Medical Technologies, Inc. | -12.42 Million USD | 233.049% |
| Orthofix Medical Inc. | -139.11 Million USD | 111.887% |
| Venus Concept Inc. | -28.3 Million USD | 158.41% |
| Accelerate Diagnostics, Inc. | -54.02 Million USD | 130.605% |
| Bioventus Inc. | -81.72 Million USD | 120.233% |
| BrainsWay Ltd. | -4.92 Million USD | 435.607% |
| Envoy Medical, Inc. | -18.37 Million USD | 190.008% |
| electroCore, Inc. | -18.8 Million USD | 187.931% |
| IceCure Medical Ltd | -15.57 Million USD | 206.159% |
| Lucid Diagnostics Inc. | -48.48 Million USD | 134.106% |
| Monogram Orthopaedics, Inc. | -17.26 Million USD | 195.757% |
| MaxCyte, Inc. | -48.29 Million USD | 134.235% |
| NeuroOne Medical Technologies Corporation | -11.95 Million USD | 238.31% |
| Nexalin Technology, Inc. | -5.69 Million USD | 390.283% |
| PAVmed Inc | -68.79 Million USD | 124.036% |
| Rapid Micro Biosystems, Inc. | -56.56 Million USD | 129.234% |
| RxSight, Inc. | -50.08 Million USD | 133.015% |
| Sight Sciences, Inc. | -57.27 Million USD | 128.871% |
| SI-BONE, Inc. | -46.93 Million USD | 135.233% |
| TELA Bio, Inc. | -44.07 Million USD | 137.516% |
| TriSalus Life Sciences, Inc. | -54.15 Million USD | 130.536% |
| Treace Medical Concepts, Inc. | -51.42 Million USD | 132.152% |
| LivaNova PLC | -68.49 Million USD | 124.14% |
| 908 Devices Inc. | -42.75 Million USD | 138.672% |
| Alphatec Holdings, Inc. | -173.39 Million USD | 109.536% |
| Nemaura Medical Inc. | -9.59 Million USD | 272.329% |
| NeuroPace, Inc. | -27.17 Million USD | 160.85% |
| LENSAR, Inc. | -12.22 Million USD | 235.214% |
| Apyx Medical Corporation | -17.25 Million USD | 195.807% |
| Cutera, Inc. | -156.23 Million USD | 110.584% |
| STRATA Skin Sciences, Inc. | -8.6 Million USD | 292.182% |
| BioSig Technologies, Inc. | -28.51 Million USD | 157.994% |
| Anika Therapeutics, Inc. | -87.63 Million USD | 118.868% |
| ClearPoint Neuro, Inc. | -22.44 Million USD | 173.667% |
| Integra LifeSciences Holdings Corporation | 111.52 Million USD | 85.174% |
| Axonics, Inc. | -26.05 Million USD | 163.458% |
| Outset Medical, Inc. | -169.77 Million USD | 109.74% |
| IRIDEX Corporation | -10 Million USD | 265.238% |
| PROCEPT BioRobotics Corporation | -109.17 Million USD | 115.146% |
| IRadimed Corporation | 20.03 Million USD | 17.469% |
| Tivic Health Systems, Inc. | -8.24 Million USD | 300.55% |
| INVO Bioscience, Inc. | -6.76 Million USD | 344.347% |
| Telesis Bio, Inc. | -35.15 Million USD | 147.042% |
| Viemed Healthcare, Inc. | 14.33 Million USD | -15.39% |
| Varex Imaging Corporation | 32.1 Million USD | 48.488% |
| Quipt Home Medical Corp. | 3.91 Million USD | -321.928% |
| Inspira Technologies Oxy B.H.N. Ltd. | -12.13 Million USD | 236.284% |
| Pulmonx Corporation | -61.93 Million USD | 126.698% |
| Dynatronics Corporation | -2.27 Million USD | 827.453% |
| Modular Medical, Inc. | -17.52 Million USD | 194.331% |
| ReShape Lifesciences Inc. | -14.63 Million USD | 212.954% |
| Semler Scientific, Inc. | 22.25 Million USD | 25.704% |
| InMode Ltd. | 195.66 Million USD | 91.549% |
| Bruker Corporation | 436.9 Million USD | 96.215% |
| Cytosorbents Corporation | -31.2 Million USD | 152.982% |
| DexCom, Inc. | 597.7 Million USD | 97.234% |
| Align Technology, Inc. | 643.33 Million USD | 97.43% |
| Viveve Medical, Inc. | -21.55 Million USD | 176.72% |
| ZimVie Inc. | -30.93 Million USD | 153.445% |
| Movano Inc. | -29.69 Million USD | 155.693% |
| Cytek Biosciences, Inc. | -27.84 Million USD | 159.384% |
| Nexalin Technology, Inc. | -5.69 Million USD | 390.283% |
| DIH Holdings US, Inc. Class A Common Stock | -3.52 Million USD | 568.689% |
| Tandem Diabetes Care, Inc. | -233.23 Million USD | 107.09% |
| Profound Medical Corp. | -28.61 Million USD | 157.784% |
| Insulet Corporation | 220 Million USD | 92.484% |
| enVVeno Medical Corporation | -25.23 Million USD | 165.518% |
| Surmodics, Inc. | -5.64 Million USD | 392.921% |
| iCAD, Inc. | -7.68 Million USD | 315.052% |
| Nuwellis, Inc. | -17.63 Million USD | 193.791% |
| Biotricity, Inc. | -8.82 Million USD | 287.3% |
| iRhythm Technologies, Inc. | -125.16 Million USD | 113.211% |
| Aethlon Medical, Inc. | -12.63 Million USD | 230.853% |
| InspireMD, Inc. | -21.14 Million USD | 178.207% |
| PAVmed Inc. | -68.79 Million USD | 124.036% |
| BIOLASE, Inc. | -17.93 Million USD | 192.186% |
| Beyond Air, Inc. | -63 Million USD | 126.244% |
| AxoGen, Inc. | -21.46 Million USD | 177.045% |
| Vivani Medical, Inc. | -26.96 Million USD | 161.322% |
| Tactile Systems Technology, Inc. | 18.04 Million USD | 8.346% |
| Inari Medical, Inc. | -14.03 Million USD | 217.84% |
| UFP Technologies, Inc. | 57.66 Million USD | 71.325% |
| QT Imaging Holdings, Inc. | -4.92 Million USD | 435.566% |
| Heart Test Laboratories, Inc. | -6.3 Million USD | 362.226% |
| Tenon Medical, Inc. | -15.72 Million USD | 205.14% |
| Autonomix Medical, Inc. Common Stock | -7.47 Million USD | 321.238% |
| Co-Diagnostics, Inc. | -42.7 Million USD | 138.719% |
| AdaptHealth Corp. | -598.4 Million USD | 102.763% |
| Sintx Technologies, Inc. | -13.35 Million USD | 223.786% |
| NanoVibronix, Inc. | -3.43 Million USD | 581.239% |
| Quanterix Corporation | -49.7 Million USD | 133.27% |
| Inspira Technologies Oxy B.H.N. Ltd. | -12.13 Million USD | 236.284% |
| Sensus Healthcare, Inc. | -382 Thousand USD | 4428.629% |
| Pacific Biosciences of California, Inc. | -334.46 Million USD | 104.944% |
| TransMedics Group, Inc. | -28.72 Million USD | 157.56% |
| ReWalk Robotics Ltd. | -23.61 Million USD | 170.029% |
| NeuroMetrix, Inc. | -7.15 Million USD | 331.215% |
| Hyperfine, Inc. | -48.11 Million USD | 134.366% |
| Establishment Labs Holdings Inc. | -65.02 Million USD | 125.429% |
| Biomerica, Inc. | -6.36 Million USD | 359.704% |
| Bone Biologics Corporation | -9.42 Million USD | 275.38% |
| AVITA Medical, Inc. | -40.4 Million USD | 140.927% |
| Bluejay Diagnostics, Inc. | -10.31 Million USD | 260.363% |
| Silk Road Medical, Inc | -59.27 Million USD | 127.898% |